THIS SOUNDS LIKE GOOD NEWS: “AstraZeneca Plc’s Crestor slashed the risk of heart attack, stroke and death by nearly half in people with normal or low cholesterol in a study, potentially opening a way to save the lives of thousands of seemingly healthy people. The benefits were shown in patients with high levels of a protein called CRP, an indicator of inflammation. CRP is tied to heart risk even in people with no additional symptoms. Crestor is approved by U.S. regulators only to lower bad cholesterol.”

I’d like to see if this is borne out by followup studies, though.